The product combining adapalene 0.1% and benzoyl peroxide 2.5% was approved as a prescription acne treatment in December 2008 for patients aged 12 years and older.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/fda-approves-otc-switch-topical-acne-treatment-2026a1000hkj?src=rss
Author :
Publish date : 2026-05-27 17:21:00
Copyright for syndicated content belongs to the linked Source.
